CHRNA1 Gene Curation
Gene-disease assertions not curated here (add link or write note):
Disease | Congenital myasthenic syndrome |
---|---|
Inheritance | Autosomal recessive |
Prevalence | 1-9/1000000 Source: orphanet |
Rapid or full curation? | Rapid Full |
ClinGen - none, in scope for Prenatal gcep. GenCC - Strong by Invitae only. BabySeq - Strong for AR Congenital myasthenic syndrome, and no conflicts. No further gene disease validity curation needed according to our SOP. | |
Clinical Validity Scoring Notes and points | Variant/Case Evidence: Segregation Evidence: Case/Control Evidence: Experimental Evidence: Source: |
Clinical Validity Points Total |
Source: |
Clinical Validity Classification Definitive (12pts) Strong (12pts) Moderate (7-11pts) Limited (0.1-6pts) No genetic evidence Refuted Disputed |
Source: |
Molecular Mechanism Loss of function Gain of function Dominant negative Unknown Other | Loss of function / Gain of function / Dominant Negative
|
Penetrance Complete (100%) High (≥80%) Moderate (<80% and >20%) Low (≤20%) (list source/PMID) |
Source: |
Age of Onset Congenital Pediatric Adolescent Adulthood Late adulthood (list source/PMID) |
|
Severity Embryonic lethal - presence of a pathogenic variant or variants is not compatible with life. The penetrance must be complete. |
|
Clinical Features |
Sources: |
HPO Terms |
|
Gene SOPs & Notes | LINK if SOP is a long document. Short notes if it is easy to digest. eg. Last known truncating variant |
Curation Summary - The @GENE@ is associated with @inheritance pattern@ @condition@, which is characterized by @clinical features@ (PMIDs). - Variable expression or severity: - Limited evidence gene: The PCNA gene has been reported in individuals with early onset autosomal recessive ataxia (PMID: 33426167, 24911150), however, evidence supporting this gene-dIsease relationship is limited |
|
Case ID, Curator name, Date, Jira ticket link |
|